购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

PF-04929113 Mesylate

产品编号 T4342Cas号 1173111-67-5
别名 PF-04929113 (Mesylate), SNX-5422 Mesylate

PF-04929113 Mesylate (SNX-5422 Mesylate) 是 SNX-2112 的前药,是一种可口服的 Hsp90 抑制剂 (Kd: 41 nM),还可诱导 Her-2 降解 (IC50: 37 nM)。

PF-04929113 Mesylate

PF-04929113 Mesylate

纯度: 99.46%
产品编号 T4342 别名 PF-04929113 (Mesylate), SNX-5422 MesylateCas号 1173111-67-5

PF-04929113 Mesylate (SNX-5422 Mesylate) 是 SNX-2112 的前药,是一种可口服的 Hsp90 抑制剂 (Kd: 41 nM),还可诱导 Her-2 降解 (IC50: 37 nM)。

规格价格库存数量
1 mg¥ 406现货
5 mg¥ 1,010现货
10 mg¥ 1,750现货
25 mg¥ 2,920现货
50 mg¥ 4,150现货
100 mg¥ 5,620现货
200 mg¥ 7,570现货
1 mL x 10 mM (in DMSO)¥ 1,390现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"PF-04929113 Mesylate"的相关化合物库

选择批次:
纯度:99.46%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37 nM).
靶点活性
HSP90:41 nM( Kd ), HER2:37 nM
体外活性
PF-04929113 在AU565细胞中有效抑制Her2(IC50:5±1 nM)和p-ERK稳定性(IC50:11±3 nM),抑制p-S6(IC50:61±22 nM)。同样,在A375细胞中,PF-04929113还能诱导Hsp70(IC50:13±3 nM)。PF-04929113(0.5、1、2、5及10 μM)浓度依赖性地降低细胞活力。此外,PF-04929113(1、3、5、7 μM)与HDAC抑制剂(PXD101、SAHA和TSA)等量组合,通过抑制PI3K/Akt/mTOR信号通路,协同诱导ATC细胞死亡。
体内活性
在HT-29人类结肠癌异种移植模型中,PF-04929113(50 mg/kg,p.o.)通过每周三次,持续三周的给药(qod × 3/2 × 3)后,强效抑制肿瘤生长。PF-04929113(20/40 mg/kg,p.o.)在小鼠中显著抑制多发性骨髓瘤(MM)的肿瘤血管生成和生长。
激酶实验
Briefly, Hsp90 from porcine spleen extract is isolated by affinity capture on a purine-affinity media. The Hsp90 loaded media is then challenged with test compound (PF-04929113) at a given concentration, ranging from 0.8 to 500 μM, and the amount of Hsp90 liberated at each concentration is determined. The resulting IC50 values are corrected for the ATP ligand concentration and presented as apparent Kd values.
细胞实验
PF-04929113 is dissolved in DMSO.Cell viability is determined by the CCK-8 Assay Kit. Cells (5 × 103/100 μL) in each well on 96-well plates are incubated overnight and treated with the drugs (PF-04929113) for an additional 4 h at 37°C. Absorbance is measured at 450 nm using a spectrophotometer.
动物实验
PF-04929113 is preformulated in 1% microcrystalline cellulose/0.5% Tween80 in water.Female nude mice are 11 to 12 weeks old and have a body weight range of 18.7?30.5 g on Day 1 of the study. Xenografts are initiated from HT-29 human colon carcinoma tumors maintained by serial transplantation in athymic nude mice. Each test mouse receives a 1 mm3 HT-29 tumor fragment implanted subcutaneously in the right flank, and the growth of tumors is monitored as the average size approached 80?120 mm3. Fourteen days later, designated as Day 1 of the study, individual tumor volumes range from 63 to 126 mm3 and the animals are placed into eight groups, each consisting of 10 mice with group mean tumor volumes of 93.2?93.9 mm3. Micronized PF-04929113 is preformulated in 1% microcrystalline cellulose/0.5% Tween80 in water. The solutions are stored at 4°C during the study and homogenized just prior to dosing. Group 1 vehicle control mice receive D5W (5% dextrose) vehicle by oral gavage beginning on Day 1, every other day for three doses, followed by two days without treatment, for three cycles ((qod × 3)/2 × 3 weeks, a total of nine doses). Groups 2 to 5 animals receive 10 at 5, 10, 25, or 50 mg/kg on the same schedule as vehicle control group ((qod × 3)/2 × 3). Each treatment is administered in a volume of 0.2 mL per 20 g of body weight (10 mL/kg) and is scaled to the body weight of the animal. Tumors are measured twice weekly using calipers.
别名PF-04929113 (Mesylate), SNX-5422 Mesylate
化学信息
分子量617.63
分子式C26H34F3N5O7S
CAS No.1173111-67-5
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 27.5 mg/mL (44.52 mM)
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM1.6191 mL8.0955 mL16.1909 mL80.9546 mL
5 mM0.3238 mL1.6191 mL3.2382 mL16.1909 mL
10 mM0.1619 mL0.8095 mL1.6191 mL8.0955 mL
20 mM0.0810 mL0.4048 mL0.8095 mL4.0477 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy PF-04929113 Mesylate | purchase PF-04929113 Mesylate | PF-04929113 Mesylate cost | order PF-04929113 Mesylate | PF-04929113 Mesylate chemical structure | PF-04929113 Mesylate in vivo | PF-04929113 Mesylate in vitro | PF-04929113 Mesylate formula | PF-04929113 Mesylate molecular weight